The Latest in Precision Medicine and Lung Cancer

Even before President Barack Obama declared it a national initiative, precision medicine has helped bring more effective treatment to patients with many types of cancer. One disease that has benefited from these treatments is lung cancer, where targeted therapies have significantly improved outcomes for patients. “When we find we have drugs targeted for a specific … Read more

How Integrative Therapies Can Help Lung Cancer Patients

Any cancer diagnosis and treatment can take a physical and emotional toll on patient. For many lung cancer patients, post-operative pain and muscle tension, as well as breathing and sleeping issues, are common side effects. To help ease some of these symptoms, patients can seek out integrative therapies, which can be used in conjunction with standard … Read more

Precision Medicine for Lung Cancer Marks Tenth Anniversary

Ten years ago researchers at Dana-Farber and in Japan published a study showing that lung cancer patients whose tumors had a malfunctioning version of a protein called Epidermal Growth Factor Receptor (EGFR) responded dramatically to a drug that specifically targets the EGFR protein. The findings launched the era of precision medicine for lung cancer, transforming … Read more

Fighting the Lung Cancer Stigma

Despite the research, the promising new drugs, the many ongoing clinical trials, lung cancer remains a disease that affects too many people, too often. For patients and family members, the disease carries an added burden: a stigma that lung cancer and smoking go hand in hand, and that lung cancer patients brought this on themselves. … Read more

Five Truths About Lung Cancer

While other kinds of cancer may receive more public attention, lung cancer remains the leading cause of cancer deaths. There are two main types of lung cancer: small cell carcinoma and non-small cell carcinoma, both of which mainly affect people over 45 years old. We spoke with Bruce E. Johnson, MD about causes and treatment options.

Promising Research Developments Stir Hopes for Melanoma, Lung, Breast and Ovarian Cancer

The growing excitement about the potential of immunotherapy treatments for cancer continued at the 2015 meeting of the American Association for Cancer Research (AACR), one of the largest cancer research meetings of the year. Several Dana-Farber investigators presented encouraging results of immunotherapy for melanoma, lung cancer, and breast cancer. F. Stephen Hodi, MD, and Leena … Read more

Microplastics and Cancer: Your Questions Answered 

In recent decades, rates of some cancers, such as colorectal cancer, have been rising in young adults under the age of 50. One possible explanation for this rise is a parallel rise in obesity rates and changes in diet, activity levels and lifestyle.   However, says Kimmie Ng, MD, MPH, director of Dana-Farber’s Young-Onset Colorectal Cancer … Read more

Breast Cancer and Young People of Asian and Pacific Islander (AAPI) Descent: What You Need to Know 

Between 2000 and 2021, breast cancer rates in people under 50 of Asian or Pacific Islander decent rose by nearly 50%, from 36 to 55 cases per 100,000, with sharper increases between 2020 and 2021. Rates of breast cancer in young people are known to be rising in general, but this rate increase, according to … Read more

Patient Takes Steps Toward Proactive Care Following Three Cancer Diagnoses 

Elizabeth Johnston, then 37, was healthy and busy with two young children and a blossoming career running a public relations firm in Connecticut. One of her clients is the Hartford Marathon Foundation and in 2015, she decided to start running smaller stretches herself.   “I was in the best shape of my life,” Johnston recalls.   Little … Read more